Kevin Robert Flaherty MD MS
Critical Care Medicine, Pleural Disease
Associate Professor, Internal Medicine, University of Michigan Medical School
Join to view full profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Fax+1 734-615-5348
Dr. Flaherty is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2000
Indiana University School of MedicineResidency, Internal Medicine, 1993 - 1997- Indiana University School of MedicineClass of 1993
Certifications & Licensure
MI State Medical License 1997 - 2028
IN State Medical License 1994 - 2003
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Metabolomic profiling reveals distinct and shared biology in COPD and IPF.Aldric Rosario, Nicole Prince, Shariq Madha-Krause, Sharon M Lutz, Julian E Hecker
Metabolomics. 2026-08-22 - Survival According to Radiomic and Visual UIP Classification in Fibrotic ILD.Jennifer M Wang, Janelle V Pugashetti, James Thompson, Edward Kang, Ella A Kazerooni
Chest. 2026-08-12 - Progressive pulmonary fibrosis: a state-of-the-art review.Vincent Cottin, Kevin Brown, Kevin R Flaherty, Martin Kolb, David A Lynch
The European Respiratory Journal. 2026-06-11
Journal Articles
- Quantitative HRCT Fibrosis Score: Performance Characteristics in Idiopathic Pulmonary FibrosisMarvin I Schwarz, Kevin R Flaherty, The European Respiratory Journal
- Stability or Improvement in Forced Vital Capacity with Nintedanib in Patients with IPFKevin Flaherty, MD, The European Respiratory Journal
Other
- Nonspecific interstitial pneumoniaFlaherty KR
http://www.uptodate.com/contents/nonspecific-interstitial-pneumonia
UpToDate, Wolters Kluwer Health - 2012-05-11
Press Mentions
If Biopsy Needed for ILD Diagnosis, Start with Less-Invasive Option, Trial SuggestsApril 21st, 2024
New Analyses of Ofev® Data in Patients with Chronic Fibrosing ILDs Available During American Thoracic Society CongressAugust 5th, 2020
Nintedanib Approved for Chronic Fibrosing Interstitial Lung Disease with Progressive PhenotypeMarch 18th, 2020
Grant Support
- Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases studyUNIVERSITY OF MICHIGAN AT ANN ARBOR2019–2026
- Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases studyUNIVERSITY OF MICHIGAN AT ANN ARBOR2019–2026
- Short Term Biomedical Research Training Program for StudentsUNIVERSITY OF MICHIGAN AT ANN ARBOR1980–2025
- Forging A Road To Personalized Medicine In Interstitial Lung DiseasesNational Heart, Lung, And Blood Institute2012
- Longitudinal, Computer Assisted Analysis In IPFNational Heart, Lung, And Blood Institute2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
